CSL Limited (OTCMKTS:CSLLY - Get Free Report) was the recipient of a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 11,800 shares, an increase of 151.1% from the December 31st total of 4,700 shares. Based on an average trading volume of 159,800 shares, the days-to-cover ratio is currently 0.1 days.
CSL Stock Performance
Shares of CSL stock traded up $0.07 during trading on Wednesday, hitting $85.23. The stock had a trading volume of 144,418 shares, compared to its average volume of 69,933. The firm's fifty day simple moving average is $88.30 and its 200-day simple moving average is $95.65. CSL has a 12 month low of $83.31 and a 12 month high of $109.00. The company has a debt-to-equity ratio of 0.58, a current ratio of 2.18 and a quick ratio of 0.97.
Wall Street Analysts Forecast Growth
Separately, The Goldman Sachs Group raised CSL to a "strong-buy" rating in a research note on Thursday, January 16th.
View Our Latest Stock Report on CSLLY
About CSL
(
Get Free Report)
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CSL, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CSL wasn't on the list.
While CSL currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
